Loading…
Designer Anabolic Steroid Control Act of 2014
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
94pct
203d open
vs 5,821 other HR bills in the 113th — cohort avg 49d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (12)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2015 · first_quarter · Alcohol and Drug Abuse
S.2012/H.R.4771: Designer Anabolic Steroid Control Act. Reauthorization of the U.S. Anti-Doping Agency. Funding for U.S. Anti-Doping Agency.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
HR 83 - Consolidated and Further Continuing Appropriations Act: Funding for Title VII Health Professions Grants, AHRQ. HR 647 Better Life Experience Act: Opposing the use of savings in Medicare for non-Medicare programs. HR 2415 (S. 1184) - Treat and Reduce Obesity Act: Seeking House and Senate cosponsors for obesity legislation. HR 3547 - FY 2015 funding Increases in AHRQ, Title VII section 747, NHSC, Teaching Health Center planning grants: Federal spending priorities to support workforce, research. HR 5481 - Urge Leadership and member offices to support bill during lame-duck session; urge CMS to shorted reporting period for 2015. HR 4771 (S. 2021) - Designer Anabolic Steriod Control Act: Restricting access to anabolic steroids. S. 1184 - Treat and Reduce Obesity Act: Seeking House and Senate cosponsors for obesity legislation. S. 1759 - Teaching Health Center Reauthorization Act GME program: Teaching Health Centers Graduate Medication Education. S. 2978 - Teaching Health Center Reauthorization Act GME program: Teaching Health Centers Graduate Medication Education. S. 2229 - Teaching Health Center Reauthorization Act GME program: Teaching Health Centers Graduate Medication Education. S. 2694 - Ensuring Access to Primary Care for Women and Children Act: Extending for 2 years the requirement that Medicaid programs pay primary care physicians at least as much as Medicare Does; Advocate for extension of Medicaid parity which expires at the end of 2014; Urge senators to co-sponsor S. 2694. S. 2917 (HR 5729): Adding Ebola to the FDA priority Review Voucher Program Act: Adding Ebola drug research to an existing FDA priority review program. No Bill Number - SGR Repeal and Replace Process: Advocate for SGR repeal and new physician payment system that pays for value and primary-care; Repealing the current physician payment formula for Medicare. No Bill Number - Graduate Medical Education: Explain and advocate for AAFP's policy proposals on GME. No Bill Number - Addressing health care fragmentation and promoting Triple Aim of improved care and health at lower cost: Promoting health reforms that recognize the value of family medicine and primary care. No Bill Number - National Service Corps trust fund reauthorization, appropriation: NHSC scholarship, debt relief and physicians for underserved. No Bill Number - Ebola Public Health Threat: Preventing the spread of Ebola. No Bill Number - Oppose cuts to pre-resident payment for Teaching Health Center GME: Maintain the sustainability of the THCGME program. No Bill Number - Urge Congress to prevent primary care cliff cuts to THCGME, NHSC &CHCs: Protect primary care spending. No Bill Number - Medicare EHR incentive payments: Concerns over attestation process. No Bill Number - Medicare Advance Care Planning - Urge CMS to cover SPT codes for ACP services. No Bill Number - Medicare Physician Payment: Comments on 2015 final payments. No Bill Number - Veterans Affairs copayments for medications in 2015: Family Physicians ability to prescribe to VA Patients. No Bill Number - Nomination to HIV/AIDS committee: Nominated a family physician to an advisory committee. No Bill Number - Nomination to Medicare Evidence Based MEDCAC: Nominated a family physician to an advisory committee. No Bill Number - Continuing Medical Education - Urged CMS to not change Open Payment CME Policy. No Bill Number - National Defense Authorization Act: Opposing provision to prevent DOD from implementing restrictions on tobacco sales and use. No Bill Number - Confirmation of the Nominee for Surgeon General: Supporting the nomination of Dr. Murthy as Surgeon General. No Bill Number - Copayments for medications in 2015: Supporting the freezing of copayments in the VHA and allowing vets to fill perscriptions from Non-VHA Physicians. No Bill Number - Medicare EvidenceDevelopment and Coverage Advisory Committee: Offering names of family physicians who could serve on the committee. No Bill Number - Presidential Advisory Counsel on HIV/AIDS - Offering the nams of family physicians to serve on the council. No Bill Number - Children's Health Insurance Program: Supporting the reauthorization of the Children's Health Insurance Program. No Bill Number - Healthcare Infection Control Practices Advisory Committee - Offering names of family physicisans to serve on committee. No Bill Number - Health Insurance Marketplace Issues and Provider involvement with Patient Enrollment: Network adequacy, patient enrollment in marketplaces.
2014 · fourth_quarter · Pharmacy
S. 2021 (HR 4771) Designer Anabolic Steriod Control Act - Supporting the nomination of Dr. Murthy as Surgeon General.
Client expense: $514,251 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
2014 · fourth_quarter · Pharmacy
S. 2021 (HR 4771) Designer Anabolic Steriod Control Act - Supporting the nomination of Dr. Murthy as Surgeon General.
Client expense: $514,251 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
2014 · fourth_quarter · Health Issues
HR 83 - Consolidated and Further Continuing Appropriations Act: Funding for Title VII Health Professions Grants, AHRQ. HR 647 Better Life Experience Act: Opposing the use of savings in Medicare for non-Medicare programs. HR 2415 (S. 1184) - Treat and Reduce Obesity Act: Seeking House and Senate cosponsors for obesity legislation. HR 3547 - FY 2015 funding Increases in AHRQ, Title VII section 747, NHSC, Teaching Health Center planning grants: Federal spending priorities to support workforce, research. HR 5481 - Urge Leadership and member offices to support bill during lame-duck session; urge CMS to shorted reporting period for 2015. HR 4771 (S. 2021) - Designer Anabolic Steriod Control Act: Restricting access to anabolic steroids. S. 1184 - Treat and Reduce Obesity Act: Seeking House and Senate cosponsors for obesity legislation. S. 1759 - Teaching Health Center Reauthorization Act GME program: Teaching Health Centers Graduate Medication Education. S. 2978 - Teaching Health Center Reauthorization Act GME program: Teaching Health Centers Graduate Medication Education. S. 2229 - Teaching Health Center Reauthorization Act GME program: Teaching Health Centers Graduate Medication Education. S. 2694 - Ensuring Access to Primary Care for Women and Children Act: Extending for 2 years the requirement that Medicaid programs pay primary care physicians at least as much as Medicare Does; Advocate for extension of Medicaid parity which expires at the end of 2014; Urge senators to co-sponsor S. 2694. S. 2917 (HR 5729): Adding Ebola to the FDA priority Review Voucher Program Act: Adding Ebola drug research to an existing FDA priority review program. No Bill Number - SGR Repeal and Replace Process: Advocate for SGR repeal and new physician payment system that pays for value and primary-care; Repealing the current physician payment formula for Medicare. No Bill Number - Graduate Medical Education: Explain and advocate for AAFP's policy proposals on GME. No Bill Number - Addressing health care fragmentation and promoting Triple Aim of improved care and health at lower cost: Promoting health reforms that recognize the value of family medicine and primary care. No Bill Number - National Service Corps trust fund reauthorization, appropriation: NHSC scholarship, debt relief and physicians for underserved. No Bill Number - Ebola Public Health Threat: Preventing the spread of Ebola. No Bill Number - Oppose cuts to pre-resident payment for Teaching Health Center GME: Maintain the sustainability of the THCGME program. No Bill Number - Urge Congress to prevent primary care cliff cuts to THCGME, NHSC &CHCs: Protect primary care spending. No Bill Number - Medicare EHR incentive payments: Concerns over attestation process. No Bill Number - Medicare Advance Care Planning - Urge CMS to cover SPT codes for ACP services. No Bill Number - Medicare Physician Payment: Comments on 2015 final payments. No Bill Number - Veterans Affairs copayments for medications in 2015: Family Physicians ability to prescribe to VA Patients. No Bill Number - Nomination to HIV/AIDS committee: Nominated a family physician to an advisory committee. No Bill Number - Nomination to Medicare Evidence Based MEDCAC: Nominated a family physician to an advisory committee. No Bill Number - Continuing Medical Education - Urged CMS to not change Open Payment CME Policy. No Bill Number - National Defense Authorization Act: Opposing provision to prevent DOD from implementing restrictions on tobacco sales and use. No Bill Number - Confirmation of the Nominee for Surgeon General: Supporting the nomination of Dr. Murthy as Surgeon General. No Bill Number - Copayments for medications in 2015: Supporting the freezing of copayments in the VHA and allowing vets to fill perscriptions from Non-VHA Physicians. No Bill Number - Medicare EvidenceDevelopment and Coverage Advisory Committee: Offering names of family physicians who could serve on the committee. No Bill Number - Presidential Advisory Counsel on HIV/AIDS - Offering the nams of family physicians to serve on the council. No Bill Number - Children's Health Insurance Program: Supporting the reauthorization of the Children's Health Insurance Program. No Bill Number - Healthcare Infection Control Practices Advisory Committee - Offering names of family physicisans to serve on committee. No Bill Number - Health Insurance Marketplace Issues and Provider involvement with Patient Enrollment: Network adequacy, patient enrollment in marketplaces.
| Republican |
| UT |
| Mark E. Amodei | Republican | NV |
| Tammy Duckworth | Democratic | IL |
Client expense: $514,251 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
Client expense: $514,251 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
2014 · fourth_quarter · Pharmacy
S. 2021 (HR 4771) Designer Anabolic Steriod Control Act - Supporting the nomination of Dr. Murthy as Surgeon General.
Client expense: $2,438,717 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
2014 · fourth_quarter · Health Issues
HR 83 - Consolidated and Further Continuing Appropriations Act: Funding for Title VII Health Professions Grants, AHRQ. HR 647 Better Life Experience Act: Opposing the use of savings in Medicare for non-Medicare programs. HR 2415 (S. 1184) - Treat and Reduce Obesity Act: Seeking House and Senate cosponsors for obesity legislation. HR 3547 - FY 2015 funding Increases in AHRQ, Title VII section 747, NHSC, Teaching Health Center planning grants: Federal spending priorities to support workforce, research. HR 5481 - Urge Leadership and member offices to support bill during lame-duck session; urge CMS to shorted reporting period for 2015. HR 4771 (S. 2021) - Designer Anabolic Steriod Control Act: Restricting access to anabolic steroids. S. 1184 - Treat and Reduce Obesity Act: Seeking House and Senate cosponsors for obesity legislation. S. 1759 - Teaching Health Center Reauthorization Act GME program: Teaching Health Centers Graduate Medication Education. S. 2978 - Teaching Health Center Reauthorization Act GME program: Teaching Health Centers Graduate Medication Education. S. 2229 - Teaching Health Center Reauthorization Act GME program: Teaching Health Centers Graduate Medication Education. S. 2694 - Ensuring Access to Primary Care for Women and Children Act: Extending for 2 years the requirement that Medicaid programs pay primary care physicians at least as much as Medicare Does; Advocate for extension of Medicaid parity which expires at the end of 2014; Urge senators to co-sponsor S. 2694. S. 2917 (HR 5729): Adding Ebola to the FDA priority Review Voucher Program Act: Adding Ebola drug research to an existing FDA priority review program. No Bill Number - SGR Repeal and Replace Process: Advocate for SGR repeal and new physician payment system that pays for value and primary-care; Repealing the current physician payment formula for Medicare. No Bill Number - Graduate Medical Education: Explain and advocate for AAFP's policy proposals on GME. No Bill Number - Addressing health care fragmentation and promoting Triple Aim of improved care and health at lower cost: Promoting health reforms that recognize the value of family medicine and primary care. No Bill Number - National Service Corps trust fund reauthorization, appropriation: NHSC scholarship, debt relief and physicians for underserved. No Bill Number - Ebola Public Health Threat: Preventing the spread of Ebola. No Bill Number - Oppose cuts to pre-resident payment for Teaching Health Center GME: Maintain the sustainability of the THCGME program. No Bill Number - Urge Congress to prevent primary care cliff cuts to THCGME, NHSC &CHCs: Protect primary care spending. No Bill Number - Medicare EHR incentive payments: Concerns over attestation process. No Bill Number - Medicare Advance Care Planning - Urge CMS to cover SPT codes for ACP services. No Bill Number - Medicare Physician Payment: Comments on 2015 final payments. No Bill Number - Veterans Affairs copayments for medications in 2015: Family Physicians ability to prescribe to VA Patients. No Bill Number - Nomination to HIV/AIDS committee: Nominated a family physician to an advisory committee. No Bill Number - Nomination to Medicare Evidence Based MEDCAC: Nominated a family physician to an advisory committee. No Bill Number - Continuing Medical Education - Urged CMS to not change Open Payment CME Policy. No Bill Number - National Defense Authorization Act: Opposing provision to prevent DOD from implementing restrictions on tobacco sales and use. No Bill Number - Confirmation of the Nominee for Surgeon General: Supporting the nomination of Dr. Murthy as Surgeon General. No Bill Number - Copayments for medications in 2015: Supporting the freezing of copayments in the VHA and allowing vets to fill perscriptions from Non-VHA Physicians. No Bill Number - Medicare EvidenceDevelopment and Coverage Advisory Committee: Offering names of family physicians who could serve on the committee. No Bill Number - Presidential Advisory Counsel on HIV/AIDS - Offering the nams of family physicians to serve on the council. No Bill Number - Children's Health Insurance Program: Supporting the reauthorization of the Children's Health Insurance Program. No Bill Number - Healthcare Infection Control Practices Advisory Committee - Offering names of family physicisans to serve on committee. No Bill Number - Health Insurance Marketplace Issues and Provider involvement with Patient Enrollment: Network adequacy, patient enrollment in marketplaces.
Client expense: $2,438,717 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
2014 · fourth_quarter · Food Industry (safety, labeling, etc.)
H.R. 83, FY2015 Omnibus Appropriations Act. For increased funding for FDA to implement and enforce dietary supplement regulations. Prompt publication by FDA of new dietary ingredient guidance for dietary supplements. Passage of H.R.4771/S/2012, Designer Anabolic Steroids Control Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Passage of H.R.4771/S/2012, Designer Anabolic Steroids Control Act.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Full implementation and enforcement of dietary supplement laws and regulations. Passage of H.R.4771/S/2012, Designer Anabolic Steroids Control Act.
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2014 · fourth_quarter · Food Industry (safety, labeling, etc.)
Full implementation and enforcement of dietary supplement laws and regulations. Passage of H.R.4771/S/2012, Designer Anabolic Steroids Control Act.
Client expense: Not reported · Firm income: $10,000
Government targets: SENATE
2014 · fourth_quarter · Consumer Issues/Safety/Products
H.R. 4771 - Designer Anabolic Steroid Control Act, a bill to amend the Controlled Substances Act to more effectively regulate anabolic steroids; all provisions relating to dietary supplements
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Alcohol and Drug Abuse
S. 2012/H.R.4771: Designer Anabolic Steroid Control Act of 2014. Reauthorization of the U.S. Anti-Doping Agency. Funding for USADA.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
S. 2021 (HR 4771) Designer Anabolic Steriod Control Act - Supporting the nomination of Dr. Murthy as Surgeon General.
Client expense: Not reported · Firm income: $2,438,717
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
2014 · fourth_quarter · Health Issues
HR 83 - Consolidated and Further Continuing Appropriations Act: Funding for Title VII Health Professions Grants, AHRQ. HR 647 Better Life Experience Act: Opposing the use of savings in Medicare for non-Medicare programs. HR 2415 (S. 1184) - Treat and Reduce Obesity Act: Seeking House and Senate cosponsors for obesity legislation. HR 3547 - FY 2015 funding Increases in AHRQ, Title VII section 747, NHSC, Teaching Health Center planning grants: Federal spending priorities to support workforce, research. HR 5481 - Urge Leadership and member offices to support bill during lame-duck session; urge CMS to shorted reporting period for 2015. HR 4771 (S. 2021) - Designer Anabolic Steriod Control Act: Restricting access to anabolic steroids. S. 1184 - Treat and Reduce Obesity Act: Seeking House and Senate cosponsors for obesity legislation. S. 1759 - Teaching Health Center Reauthorization Act GME program: Teaching Health Centers Graduate Medication Education. S. 2978 - Teaching Health Center Reauthorization Act GME program: Teaching Health Centers Graduate Medication Education. S. 2229 - Teaching Health Center Reauthorization Act GME program: Teaching Health Centers Graduate Medication Education. S. 2694 - Ensuring Access to Primary Care for Women and Children Act: Extending for 2 years the requirement that Medicaid programs pay primary care physicians at least as much as Medicare Does; Advocate for extension of Medicaid parity which expires at the end of 2014; Urge senators to co-sponsor S. 2694. S. 2917 (HR 5729): Adding Ebola to the FDA priority Review Voucher Program Act: Adding Ebola drug research to an existing FDA priority review program. No Bill Number - SGR Repeal and Replace Process: Advocate for SGR repeal and new physician payment system that pays for value and primary-care; Repealing the current physician payment formula for Medicare. No Bill Number - Graduate Medical Education: Explain and advocate for AAFP's policy proposals on GME. No Bill Number - Addressing health care fragmentation and promoting Triple Aim of improved care and health at lower cost: Promoting health reforms that recognize the value of family medicine and primary care. No Bill Number - National Service Corps trust fund reauthorization, appropriation: NHSC scholarship, debt relief and physicians for underserved. No Bill Number - Ebola Public Health Threat: Preventing the spread of Ebola. No Bill Number - Oppose cuts to pre-resident payment for Teaching Health Center GME: Maintain the sustainability of the THCGME program. No Bill Number - Urge Congress to prevent primary care cliff cuts to THCGME, NHSC &CHCs: Protect primary care spending. No Bill Number - Medicare EHR incentive payments: Concerns over attestation process. No Bill Number - Medicare Advance Care Planning - Urge CMS to cover SPT codes for ACP services. No Bill Number - Medicare Physician Payment: Comments on 2015 final payments. No Bill Number - Veterans Affairs copayments for medications in 2015: Family Physicians ability to prescribe to VA Patients. No Bill Number - Nomination to HIV/AIDS committee: Nominated a family physician to an advisory committee. No Bill Number - Nomination to Medicare Evidence Based MEDCAC: Nominated a family physician to an advisory committee. No Bill Number - Continuing Medical Education - Urged CMS to not change Open Payment CME Policy. No Bill Number - National Defense Authorization Act: Opposing provision to prevent DOD from implementing restrictions on tobacco sales and use. No Bill Number - Confirmation of the Nominee for Surgeon General: Supporting the nomination of Dr. Murthy as Surgeon General. No Bill Number - Copayments for medications in 2015: Supporting the freezing of copayments in the VHA and allowing vets to fill perscriptions from Non-VHA Physicians. No Bill Number - Medicare EvidenceDevelopment and Coverage Advisory Committee: Offering names of family physicians who could serve on the committee. No Bill Number - Presidential Advisory Counsel on HIV/AIDS - Offering the nams of family physicians to serve on the council. No Bill Number - Children's Health Insurance Program: Supporting the reauthorization of the Children's Health Insurance Program. No Bill Number - Healthcare Infection Control Practices Advisory Committee - Offering names of family physicisans to serve on committee. No Bill Number - Health Insurance Marketplace Issues and Provider involvement with Patient Enrollment: Network adequacy, patient enrollment in marketplaces.
Client expense: Not reported · Firm income: $2,438,717
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
2014 · fourth_quarter · Taxation/Internal Revenue Code
Policies to support renewable energy in the context of tax reform. Extension of expired PTC/ITC through 2015, HR 4771, Subtitle C, Section 151.
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
2014 · fourth_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. Monitor legislative and administrative action related to point-of-care instruments. Monitor legislative and administrative action related to streamlined pathways to market for breakthrough technologies. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor activities related to House Energy and Commerce Committees 21st Century Cures Initiative. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act. S. 2917, Adding Ebola to the FDA Priority Review Voucher Program Act. H.R. 3969, Preventing Abuse of Cough Treatments Act of 2014 or the PACT Act. S. 644, Preventing Abuse of Cough Treatments Act of 2013 or the PACT Act.
Client expense: $1,240,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2014 · fourth_quarter · Food Industry (safety, labeling, etc.)
Dietary Supplements - S. 1425 - Dietary Supplement Labeling Act. Expands registration requirements for dietary supplement manufacturing or processing facilities; requires development of a definition of "conventional food," including foods marketed as dietary supplements; all sections. H.R. 4771/S. 2012 - Designer Anabolic Steroid Control Act (DASCA). Food and Drug Administration (FDA) regulation of anabolic steroids; all sections. Became Public Law 113-260. Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues."
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Food Industry (safety, labeling, etc.)
Dietary SupplementsS. 1425 - Dietary Supplement Labeling Act. Expands registration requirements for dietary supplement manufacturing or processing facilities; requires development of a definition of "conventional food," including foods marketed as dietary supplements; all sections. H.R. 4771/S. 2012 - Designer Anabolic Steroid Control Act (DASCA). Food and Drug Administration (FDA) regulation of anabolic steroids; all sections. Became Public Law 113-260. Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues."
Client expense: $230,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Food Industry (safety, labeling, etc.)
S. 2012 Designer Anabolic Steroid Control Act of 2014 H.R. 4771 Designer Anabolic Steroid Control Act of 2014
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Food Industry (safety, labeling, etc.)
Dietary supplement and food safety issues. Monitor the following: New Dietary Ingredient Guidance issues. H.R.1699/S.809, Genetically Engineered Food Right-to-Know Act, GMO food issues. Food safety modernization regulations, generally. S.1425, Dietary Supplement Labeling Act, Regulations of Dietary Supplements H.R.4771/S.2012, Designer Anabolic Steroid Control Act (DASCA), Dietary supplement enforcement issues.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Food Industry (safety, labeling, etc.)
HR 4771/S2012 - the Designer Anabolic Steroid Control Act. I met with various members of Congress and staff to discuss Pharmavite support for this proactive measure.
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding dietary supplements: H.R.4771/S.2012, Designer Anabolic Steroid Control Act Dehydroepiandrosterone Abuse Reduction Act Dimethylamylamine (DMAA)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. Monitor legislative and administrative action related to point-of-care instruments. Monitor legislative and administrative action related to streamlined pathways to market for breakthrough technologies. Monitor legislative and administrative action related to access to medical supplies. Monitor legislative and administration action related to Tropical Disease Priority Review Voucher Program. Monitor activities related to House Energy and Commerce Committees 21st Century Cures Initiative. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 1528, Veterinary Medicine Mobility Act of 2014. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act.
Client expense: $1,450,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2014 · second_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 1528, Veterinary Medicine Mobility Act of 2014. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act.
Client expense: $1,360,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2014 · third_quarter · Alcohol and Drug Abuse
S. 2012/H.R.4771: Designer Anabolic Steroid Control Act of 2014. Reauthorization of the U.S. Anti-Doping Agency.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Food Industry (safety, labeling, etc.)
H.R. 4800/S.2389, FY2015 Appropriations for the Department of Agriculture and Related Agencies. Increased funding for regulation of dietary supplements. H.R. 4771/S.2012, The Designer Anabolic Steroids Control Act. Full implementation of laws and regulations pertaining to dietary supplements. Addressing nutrient shortfalls among Americans (no specific legislation).
Client expense: Not reported · Firm income: $36,000
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
H.R. 4800/S.2389, FY2015 Appropriations for the Department of Agriculture and Related Agencies. Increased funding for regulation of dietary supplements. H.R. 4771/S.2012, The Designer Anabolic Steroids Control Act. Full implementation of laws and regulations pertaining to dietary supplements. Addressing nutrient shortfalls among Americans (no specific legislation).
Client expense: Not reported · Firm income: $36,000
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
H.R. 4771/S.2012, The Designer Anabolic Steroids Control Act. Draft legislation regarding regulation of cosmetics and cosmetics ingredients. Support for full implementation and enforcement of Dietary Supplement Health and Education Act.
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Food Industry (safety, labeling, etc.)
H.R. 4771/S.2012, The Designer Anabolic Steroids Control Act. Draft legislation regarding regulation of cosmetics and cosmetics ingredients. Support for full implementation and enforcement of Dietary Supplement Health and Education Act.
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Consumer Issues/Safety/Products
S. 2012 - Designer Anabolic Steroid Control Act, a bill to amend the Controlled Substances Act to more effectively regulate anabolic steroids; all provisions relating to dietary supplements H.R. 4771 - Designer Anabolic Steroid Control Act, a bill to amend the Controlled Substances Act to more effectively regulate anabolic steroids; all provisions relating to dietary supplements
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Food Industry (safety, labeling, etc.)
Dietary SupplementsS. 1425 - Dietary Supplement Labeling Act. Expands registration requirements for dietary supplement manufacturing or processing facilities; requires development of a definition of "conventional food," including foods marketed as dietary supplements; all sections. H.R. 4771/S. 2012 - Designer Anabolic Steroid Control Act (DASCA). Food and Drug Administration (FDA) regulation of anabolic steroids; all sections. Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues."
Client expense: $220,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding dietary supplements: H.R.4771/S.2012, Designer Anabolic Steroid Control Act Dehydroepiandrosterone Abuse Reduction Act Dimethylamylamine (DMAA)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Food Industry (safety, labeling, etc.)
Monitor the following: Dietary supplement and food safety issues. New Dietary Ingredient Guidance issues. H.R.1699/S.809, Genetically Engineered Food Right-to-Know Act, GMO food issues. National Toxicology program, Herb and botanical research and development issues. Food safety modernization regulations, generally. S.1425, Dietary Supplement Labeling Act, Regulations of Dietary Supplements H.R.4771/S.2012, Designer Anabolic Steroid Control Act (DASCA), Dietary supplement enforcement issues.
Client expense: Not reported · Firm income: $10,000
2014 · third_quarter · Food Industry (safety, labeling, etc.)
S. 2012 Designer Anabolic Steroid Control Act of 2014 H.R. 4771 Designer Anabolic Steroid Control Act of 2014
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Food Industry (safety, labeling, etc.)
Discussed FDA's NDI guidance document issued 2011 and need to have FDA issue revised draft. Support for both HR 4771 and SB 2012. Support for full enforcement of DSHEA. Dept of Commerce meeting - discuss regulatory hurdles relative to marketing dietary supplement products in China.
Client expense: $60,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Law Enforcement/Crime/Criminal Justice
H.R.4771/S.2012, Designer Anabolic Steroid Control Act Dehydroepiandrosterone Abuse Reduction Act Dimethylamylamine (DMAA)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
Monitor legislative and administrative action related to health care policy. Monitor legislative and administrative action related to drug user fees. Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment. Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace). Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising. Monitor legislative and administrative action related to the 340B Drug Pricing Program. Monitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill. H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013. HR 3204, Drug Quality and Security Act. Provisions related to drug distribution. H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution. S. 1256, Preventing Antibiotic Resistance Act of 2013. S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013. H.R. 1528, Veterinary Medicine Mobility Act of 2014. H.R. 4771, Designer Anabolic Steroid Control Act of 2014. S. 2012, Designer Anabolic Steroid Control Act of 2014. Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148. H.R. 1295, Medical Device Tax Elimination Act.
Client expense: $1,340,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
2014 · second_quarter · Food Industry (safety, labeling, etc.)
HR 4771, Designer Anabolic Steroid Control Act
Client expense: $530,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
2014 · second_quarter · Food Industry (safety, labeling, etc.)
Dietary SupplementsS. 1425 - Dietary Supplement Labeling Act. Expands registration requirements for dietary supplement manufacturing or processing facilities; requires development of a definition of "conventional food," including foods marketed as dietary supplements; all sections. H.R. 4771/S. 2012 - Designer Anabolic Steroid Control Act (DASCA). Food and Drug Administration (FDA) regulation of anabolic steroids; all sections. Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues."
Client expense: $230,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Law Enforcement/Crime/Criminal Justice
Support for H.R. 4771/S.2012 the Designer Anabolic Steroids Control Act.
Client expense: Not reported · Firm income: $36,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Law Enforcement/Crime/Criminal Justice
Support for H.R. 4771/S.2012, the Designer Anabolic Steroids Control Act.
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Health Issues
Full implementation and enforcement of laws and regulations related to dietary supplements. Support for H.R. 4771/S.2012, the Designer Anabolic Steroids Control Act.
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Consumer Issues/Safety/Products
S. 2012 - Designer Anabolic Steroid Control Act, a bill to amend the Controlled Substances Act to more effectively regulate anabolic steroids; all provisions relating to dietary supplements H.R. 4771 - Designer Anabolic Steroid Control Act, a bill to amend the Controlled Substances Act to more effectively regulate anabolic steroids; all provisions relating to dietary supplements
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Food Industry (safety, labeling, etc.)
New Dietary Ingredient Regulation S. 2012 Designer Anabolic Steroid Control Act of 2014 H.R. 4771 Designer Anabolic Steroid Control Act of 2014
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Law Enforcement/Crime/Criminal Justice
Issues regarding dietary supplements: H.R.4771/S.2012, Designer Anabolic Steroid Control Act Dehydroepiandrosterone Abuse Reduction Act Dimethylamylamine (DMAA)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Food Industry (safety, labeling, etc.)
Dietary supplement and food safety issues. Monitor New Dietary Ingredient Guidance issues. H.R.1699/S.809, Genetically Engineered Food Right-to-Know Act, GMO food issues. National Toxicology program, Monitor herb and botanical research and development issues. Food safety modernization regulations, generally. S.1425, Dietary Supplement Labeling Act, Regulations of Dietary Supplements H.R.4771/S.2012, Designer Anabolic Steroid Control Act (DASCA), Dietary supplement enforcement issues.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Food Industry (safety, labeling, etc.)
Support for HR 4771 and SB 2012 Support for full funding of Military Commissaries Support for prompt publication of FDA's NDI guidance
Client expense: $70,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE